Znanstveni rad - Prethodno/kratko priopćenje
Serum procalcitonin in Philadelphia-negative myeloproliferative neoplasms
Wiener klinische Wochenschrift, 133 (2021), 1-2; 62-64. https://doi.org/10.1007/s00508-020-01651-8

Krečak, Ivan; Peran, Nena; Lapić, Ivana; Gverić-Krečak, Velka; Krečak, Filip; Rončević, Pavle; Duraković, Nadira

Citirajte ovaj rad

Krečak, I., Peran, N., Lapić, I., Gverić Krečak, V., Krečak, F., Rončević, P. i Duraković, N. (2021). Serum procalcitonin in Philadelphia-negative myeloproliferative neoplasms. Wiener klinische Wochenschrift, 133. (1-2), 62-64. doi: 10.1007/s00508-020-01651-8

Krečak, Ivan, et al. "Serum procalcitonin in Philadelphia-negative myeloproliferative neoplasms." Wiener klinische Wochenschrift, vol. 133, br. 1-2, 2021, str. 62-64. https://doi.org/10.1007/s00508-020-01651-8

Krečak, Ivan, Nena Peran, Ivana Lapić, Velka Gverić Krečak, Filip Krečak, Pavle Rončević i Nadira Duraković. "Serum procalcitonin in Philadelphia-negative myeloproliferative neoplasms." Wiener klinische Wochenschrift 133, br. 1-2 (2021): 62-64. https://doi.org/10.1007/s00508-020-01651-8

Krečak, I., et al. (2021) 'Serum procalcitonin in Philadelphia-negative myeloproliferative neoplasms', Wiener klinische Wochenschrift, 133(1-2), str. 62-64. doi: 10.1007/s00508-020-01651-8

Krečak I, Peran N, Lapić I, Gverić Krečak V, Krečak F, Rončević P, i sur.. Serum procalcitonin in Philadelphia-negative myeloproliferative neoplasms. Wiener klinische Wochenschrift [Internet]. 2021. [pristupljeno 10.10.2024.];133(1-2):62-64. doi: 10.1007/s00508-020-01651-8

I. Krečak, et al., "Serum procalcitonin in Philadelphia-negative myeloproliferative neoplasms", Wiener klinische Wochenschrift, vol. 133, br. 1-2, str. 62-64, 2021. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:454303. [Citirano: 10.10.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.